WNPRC STEM CELL RESOURCE

WNPRC干细胞资源

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objective: To maintain and further develop a specialized resource for studies relating to pluripotent stem cell research. Allocation of Resource Access: To date, the stem cell resource unit at the Wisconsin National Primate Research Center provides frozen rhesus and marmoset ES cells to interested investigators. No request has been denied. Additionally, the stem cell resource unit provides zebrafish bFGF for culturing primate ES cells. Since last submission 3 new investigators have received the recombinant protein bringing the total number of investigators receiving zbFGF on a regular basis to 21. Over 330mg of zbFGF has been distributed to date. This has saved investigators over $1,000,000. The DNA plasmid used to purify the protein itself is now available through Addgene (www.addgene.com) and was sent to 13 new investigators in 2008 bringing the total number of investigators to receive this plasmid to 39. Lastly, in 2009, 2 investigators requested and received rhesus ES cell provided by the stem cell resources unit and distributed by the WiCell Research Institute. Dissemination: Knowledge is disseminated to the scientific community via publications in peer reviewed journals and scientific meeting attendance. The Wisconsin National Primate Research Center also holds quarterly research retreats to create increased communication between the various service and resource units. Training: Training in culture techniques of primate embryonic stem cells is available. Many new investigators have taken advantage of this resource in previous reporting periods however there have been no new investigators trained this year. Progress: Past and present members of stem cell resources developed a method for generating iPS cells without vector transgene sequences; this work is referenced below in the highlights portion. We have provided ips cell derivation for disease specific cell lines for several UW investigators. To date, 4 disease cell lines have been used for ips cell generation and a total of 55 clones have been cultured and frozen for future use. We are also beginning to start reprogramming experiments on rhesus macaque fibroblasts. Other groups have successfully reprogrammed primate cells and we will be following similar protocols. Highlights: Past and present members of stem cell resources were authors on a paper detailing a vector free method of adult cell reprogramming: Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences Junying Yu, Kejin Hu, Kim Smuga-Otto, Shulan Tian, Ron Stewart, Igor I. Slukvin, James A. Thomson Science 8 May 2009 Vol 324. No. 5928, pp 797-801. Challenges: Due to funding shortages we were unable to receive cynomologous embryos and the project came to a halt. We look forward to working with CPI to receive Mauritian cynomolougous embryos to create new cynomologous ES cell lines as described in our P51 proposal. Concerns: No concerns at this time. Stem Cell Resource support is involved in numerous journal articles that depend in part or in full on WNPRC resources.
该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员(PI)可能已经从其他NIH来源获得了主要资金, 因此可以在其他清晰的条目中代表。列出的机构是 对于中心,这不一定是调查员的机构。 目的:维护并进一步开发了与多能干细胞研究有关的研究专门资源。 资源访问的分配: 迄今为止,威斯康星州国家灵长类动物研究中心的干细胞资源单元向有兴趣的研究人员提供了冷冻的恒河类和摩尔莫斯ES细胞。没有拒绝要求。此外,干细胞资源单元提供斑马鱼BFGF用于培养灵长类动物ES细胞。自上次提交以来,3名新调查人员已收到重组蛋白,将ZBFGF的调查人员定期提高到21。迄今已分发了超过330毫克的ZBFGF。这为调查人员节省了超过1,000,000美元。现在可以通过Addgene(www.addgene.com)获得用于纯化蛋白质本身的DNA质粒,并于2008年被送往13位新的研究人员,将研究人员总数接收到39个。最后,2009年,2009年,2名调查人员要求并收到了由干细胞资源单位提供的Rhesus ES细胞,并由Wicell Research Institute分发了。 传播: 知识通过同行评审期刊和科学会议出勤的出版物传播给科学界。威斯康星州国家灵长类动物研究中心还举行季度研究务虚会,以在各种服务和资源单位之间提高沟通。 训练: 可以接受灵长类动物胚胎干细胞的培养技术培训。许多新的调查人员在以前的报告期间利用了这一资源,但是今年没有接受过新的调查人员培训。 进步: 干细胞资源的过去和现在成员开发了一种生成没有载体转基因序列的IPS细胞的方法。这项工作在下面的重点部分中引用。我们为几个UW研究者提供了针对疾病特定细胞系的IPS细胞推导。迄今为止,IPS细胞的产生已使用4种疾病细胞系,总共培养了55个克隆并冷冻以供将来使用。我们也开始在恒河猕猴成纤维细胞上重新编程实验。其他组已成功地重编程了灵长类动物细胞,我们将遵循类似的方案。 亮点: 干细胞资源的过去和现在成员是一篇论文中的作者,详细介绍了一种成年细胞重编程的矢量免费方法:人类诱导的多能干细胞无载体和转基因序列Junying Yu,Kejin Hu,Kim Smuga-Tian,Shulan Tian,Shulan Tian,Ron Stewart,Ron Stewart,Ron Stewart,Ron Stewart,Ron Stewart,Ron Stewart,Ron Stewart,Igor I.Slukvin,I.Slukvin,I.Slukvin,I.Slukvin,James Scicems Science 8 Mays Science 8 32. 59. 2009. 2009. 2009年。 797-801。 挑战: 由于资金短缺,我们无法收到C胚胚,该项目停止了。我们期待与CPI合作,以接收毛里求斯的cynomolougous胚胎,如我们的p51提案中所述,创建新的cynomologologiol ES细胞系。 问题: 目前没有问题。 干细胞资源支持涉及许多期刊文章,部分依赖于WNPRC资源。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

James Alexander Th...的其他基金

Transplantation of MHC Homozygous Vascular Progenitors in Primates
灵长类 MHC 纯合血管祖细胞移植
  • 批准号:
    9355220
    9355220
  • 财政年份:
    2016
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Transplantation of MHC Homozygous Vascular Progenitors in Primates
灵长类 MHC 纯合血管祖细胞移植
  • 批准号:
    9215301
    9215301
  • 财政年份:
    2016
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
基于人类 iPS/ES 细胞的预测神经毒性和致畸性模型
  • 批准号:
    8668606
    8668606
  • 财政年份:
    2012
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
基于人类 iPS/ES 细胞的预测神经毒性和致畸性模型
  • 批准号:
    8414419
    8414419
  • 财政年份:
    2012
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
基于人类 iPS/ES 细胞的预测神经毒性和致畸性模型
  • 批准号:
    8768889
    8768889
  • 财政年份:
    2012
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Self-Renewal and Differentiation: Molecular Events that Commit ES Cells to Exit t
自我更新和分化:使 ES 细胞退出的分子事件
  • 批准号:
    8381275
    8381275
  • 财政年份:
    2012
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
基于人类 iPS/ES 细胞的预测神经毒性和致畸性模型
  • 批准号:
    8516134
    8516134
  • 财政年份:
    2012
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
MIDWEST PROGENITOR CELL CONSORTIUM
中西部祖细胞联盟
  • 批准号:
    8358235
    8358235
  • 财政年份:
    2011
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
MIDWEST PROGENITOR CELL CONSORTIUM
中西部祖细胞联盟
  • 批准号:
    8173156
    8173156
  • 财政年份:
    2010
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
DETERMINANTS OF SELF-RENEWAL, DIFFERENTIATION, AND REPROGRAMMING OF HESCS
HECS 自我更新、分化和重新编程的决定因素
  • 批准号:
    8173148
    8173148
  • 财政年份:
    2010
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:

相似海外基金

Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
癌症病毒复制、转化和先天防御的分子基础
  • 批准号:
    10158926
    10158926
  • 财政年份:
    2020
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Nonhuman primate induced pluripotent stem cells in regenerative medicine
非人灵长类动物诱导多能干细胞在再生医学中的应用
  • 批准号:
    8241495
    8241495
  • 财政年份:
    2011
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Nonhuman primate induced pluripotent stem cells in regenerative medicine
非人灵长类动物诱导多能干细胞在再生医学中的应用
  • 批准号:
    8391654
    8391654
  • 财政年份:
    2011
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Nonhuman primate induced pluripotent stem cells in regenerative medicine
非人灵长类动物诱导多能干细胞在再生医学中的应用
  • 批准号:
    8760300
    8760300
  • 财政年份:
    2011
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别:
Repolarization of Activated Th1 Cells: a Novel Means to Treat IBD
活化 Th1 细胞的复极化:治疗 IBD 的新方法
  • 批准号:
    8051928
    8051928
  • 财政年份:
    2011
  • 资助金额:
    $ 10.33万
    $ 10.33万
  • 项目类别: